Chemours exceeded non-GAAP earnings and GAAP revenue expectations in Q2 FY2025, driven by strong demand for Opteon™ refrigerants. Substantial litigation and settlement charges led to a GAAP net loss ...

CC posts Q2 earnings and sales beat driven by volume and pricing gains, but issues softer sequential guidance.

Shares of Chemours climbed after the company said Samsung Electronics has qualified its Opteon two-phase immersion cooling fluid. The stock rose 16% to $14.44 on Wednesday. Shares are down 15% this ...

DuPont and two other companies will pay New Jersey up to $2 billion to settle environmental claims stemming from PFAS, ...

A federal judge ordered the Chemours Chemical Company to immediately stop discharging unlawful levels of cancer-causing ...

We recently published 10 Stocks With Whopping 11-97% Upside. The Chemours Company (NYSE:CC) is one of the best-performing ...

Chemours "has a history of violating its permit, knows it is violating its permit, and intends to continue violating its ...

Chemours (NYSE:CC) closed +17.9% on Wednesday to its highest level since March after announcing the successful qualification of its Opteon two-phase immersion cooling fluid by Samsung Electronics' ...

Key Insights The projected fair value for Chemours is US$17.84 based on 2 Stage Free Cash Flow to Equity Current ...

Chemours Chemical Company must immediately stop discharging dangerous forever chemicals from its facility near Parkersburg, ...

The Wilmington, Del.-based chemicals company’s loss was primarily driven by litigation-related charges tied to an ...

Chemours , DuPont and Corteva have agreed to pay $875 million over 25 years to the State of New Jersey to settle ...